SREK1IP1 pseudogene 2 (SREK1IP1P2)

SREK1IP1 pseudogene 2 (SREK1IP1P2) is identified as a **pseudogene** rather than a functional gene[8][5][7]. Pseudogenes are DNA sequences that originally derived from ancestral, functional genes but lost their capacity to encode proteins due to mutations or deletions. SREK1IP1P2 shares sequence similarity with its protein-coding paralog, SREK1IP1, yet unlike SREK1IP1, it does not interact with splicing factors or participate in cellular processes such as RNA splicing or mRNA processing[3][8]. There is no evidence supporting any biological function, role in disease, biomarker status, or interaction with known therapeutics for SREK1IP1P2[8][5][7][3]. There are no safety concerns or therapeutic challenges reported, as it is not a pharmacological or diagnostic target. Assessment: This is not a drug target. The entry is technically *incorrect* as a therapeutic target designation—it is a genomic pseudogene with no current relevance for drug action, biomarker utility, or disease association[8][5].

Other names

SREK1IP1P2SREK1IP1 pseudogene 2